Telomere length and genetic variant associations with interstitial lung disease progression and survivalChad A. Newton, Christine Kim Garcia, Imre Noth et al.|European Respiratory Journal|2019Cited by 173
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary FibrosisChad A. Newton, Christine Kim Garcia, David Zhang et al.|American Journal of Respiratory and Critical Care Medicine|2018Cited by 166
Validation of Proposed Criteria for Progressive Pulmonary FibrosisJanelle Vu Pugashetti, Justin M. Oldham, Ayodeji Adegunsoye et al.|American Journal of Respiratory and Critical Care Medicine|2022Cited by 134
Lung function trajectory in progressive fibrosing interstitial lung diseaseJustin M. Oldham, Philip L. Molyneaux, Cathryn T. Lee et al.|European Respiratory Journal|2021Cited by 123
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysisWillis S. Bowman, Justin M. Oldham, Chad A. Newton et al.|The Lancet Respiratory Medicine|2022Cited by 107